ADMINISTRATIVE CORE AND ENRICHMENT PROGRAM
行政核心和强化计划
基本信息
- 批准号:7767531
- 负责人:
- 金额:$ 35.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-12-01 至 2014-11-30
- 项目状态:已结题
- 来源:
- 关键词:Center for Translational Science ActivitiesClinicalClinical and Translational Science AwardsCollectionCore FacilityDataDatabasesDigestive System DisordersDisciplineDiseaseExtramural ActivitiesFacultyFunctional disorderFundingGastrointestinal DiseasesGastrointestinal tract structureIndividualInflammatory Bowel DiseasesInflammatory disease of the intestineInstitutesInstitutionIntestinesInvestigationLinkLiverMaintenanceMedicalMissionOutputPatientsPhenotypePhysiciansPostdoctoral FellowProcessProteomicsResearchResearch PersonnelResearch SupportResourcesSamplingScienceServicesSystemTissue ProcurementsTissuesTrainingTranslational ResearchUniversitiesWashingtonbiomedical informaticscostfunctional genomicsgraduate studentinnovationinterestmemberprofession allied to medicineprogramssuccess
项目摘要
The Washington University DDRCC is integrated with the NIH's Clinical Translational Science Award
(CTSA) sponsored Washington University Institute of Clinical Translational Sciences (ICTS), primarily through
the Clinical Component ofthe DDRCC and the ICTS Centerfor Biomedical Informatics. The DDRCC Clinical
Component is primarily focused on providing investigators with access to clinical samples for digestive
diseases related research. The collection and maintenance of clinical samples linked to longitudinal clinical
information in a manner that is responsive to our DDRCC investigators, requires a high level of clinical
expertise in accurately phenotyping the patient subjects and a high level of stringent oversight in collecting
clinical samples. For this reason, organization of tissue procurement at this institution has moved away from a
single monolithic institutional unit attempting to collect a broad array of clinical samples from patients with
many different diseases. Instead, tissue procurement is being conducted by smaller disease focused units,
such as the DDRCC sponsored facility, that are linked to each other by a common biomedical informatics
platforms (Tissue Suite and ClinPortal) developed and maintained by the CTSA-sponsored Center for
Biomedical Informatics. Furthermore, the data output from two of the Research Core Facilities, the Functional
Genomics Core and the Proteomics Core are in the process of being uploaded to databases (Profile DB)
maintained by the ICTS Center for Biomedical Informatics.
华盛顿大学DDRCC与NIH的临床翻译科学奖整合在一起
(CTSA)赞助华盛顿大学临床转化科学研究所(ICTS),主要通过
DDRCC和ICTS生物医学信息学中心的临床部分。DDRCC临床
组件主要专注于为研究人员提供访问临床样本以进行消化的功能
疾病相关研究。与纵向临床相联系的临床样本的收集和维护
以响应我们的DDRCC调查人员的方式提供信息,需要高水平的临床
在准确地对患者样本进行表型鉴定方面的专业知识和在收集过程中的高度严格监督
临床样本。由于这个原因,该机构组织组织的组织采购已不再是
单一的整体式机构单位试图从患者身上收集广泛的临床样本
许多不同的疾病。取而代之的是,组织采购是由较小的专注于疾病的单位进行的,
例如DDRCC赞助的设施,它们通过共同的生物医学信息学相互链接
由CTSA赞助的中心开发和维护的平台(组织套件和ClinPortal)
生物医学信息学。此外,来自两个研究核心设施的数据输出,功能
基因组学核心和蛋白质组学核心正在上传到数据库中(配置文件数据库)
由ICTS生物医学信息学中心维护。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nicholas O. Davidson其他文献
324 LIVER SPECIFIC DELETION OF TM6SF2 PROMOTES BOTH HEPATIC FIBROSIS AND HEPATOCELLULAR CANCER
- DOI:
10.1016/s0016-5085(20)33826-9 - 发表时间:
2020-05-01 - 期刊:
- 影响因子:
- 作者:
Elizabeth P. Newberry;Zoe Hall;Yan Xie;Elizabeth A. Molitor;Elizabeth M. Brunt;Jules Griffin;Nicholas O. Davidson - 通讯作者:
Nicholas O. Davidson
Tu1456: TAUROURSODEOXYCHOLIC ACID (TUDCA) REDUCES ER STRESS AND CLINICAL DISEASE ACTIVITY IN ULCERATIVE COLITIS: FINAL RESULTS OF A PHASE I TRIAL
- DOI:
10.1016/s0016-5085(22)62294-7 - 发表时间:
2022-05-01 - 期刊:
- 影响因子:
- 作者:
Vladimir Lamm;Ruishu Deng;Katherine Huang;Saeed Soleymanjahi;Ta-Chiang Liu;Yan Xie;Anas K. Gremida;Parakkal Deepak;Chien-Huan Chen;Nicholas O. Davidson;Miao Wang;Randal J. Kaufman;Matthew A. Ciorba - 通讯作者:
Matthew A. Ciorba
466 GENETIC MODIFIERS OF VLDL SECRETION REGULATE HEPATOCELLULAR CANCER (HCC) DEVELOPMENT
- DOI:
10.1016/s0016-5085(24)04012-5 - 发表时间:
2024-05-18 - 期刊:
- 影响因子:
- 作者:
Elizabeth P. Newberry;Saeed Soleymanjahi;Elizabeth A. Molitor;Xiuli Liu;Nicholas O. Davidson - 通讯作者:
Nicholas O. Davidson
1289 RBM47 REGULATES FUNCTIONAL EXPRESSION OF NOVEL C-TO-U RNA EDITING TARGETS AND TUMORIGENESIS IN MOUSE AND HUMAN INTESTINE
- DOI:
10.1016/s0016-5085(24)01196-x - 发表时间:
2024-05-18 - 期刊:
- 影响因子:
- 作者:
Valerie Blanc;Faisal Shurafa;Rebekah Greenspan;Elizabeth A. Molitor;Nicholas O. Davidson - 通讯作者:
Nicholas O. Davidson
Su1979 - Altered Body Composition in Patients with Short Bowel Syndrome
- DOI:
10.1016/s0016-5085(18)32325-4 - 发表时间:
2018-05-01 - 期刊:
- 影响因子:
- 作者:
Adeeti J. Chiplunker;Ling Chen;Brad W. Warner;Nicholas O. Davidson;Marc S. Levin;Deborah C. Rubin - 通讯作者:
Deborah C. Rubin
Nicholas O. Davidson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nicholas O. Davidson', 18)}}的其他基金
Intestinal Resection Associated Liver Injury and Fibrosis
小肠切除相关的肝损伤和纤维化
- 批准号:
10366528 - 财政年份:2021
- 资助金额:
$ 35.57万 - 项目类别:
Intestinal Resection Associated Liver Injury and Fibrosis
小肠切除相关的肝损伤和纤维化
- 批准号:
10492758 - 财政年份:2021
- 资助金额:
$ 35.57万 - 项目类别:
Impaired VLDL secretion, progression and reversal of hepatic fibrogenesis
VLDL 分泌受损、肝纤维化进展和逆转
- 批准号:
9978062 - 财政年份:2019
- 资助金额:
$ 35.57万 - 项目类别:
Impaired VLDL secretion, progression and reversal of hepatic fibrogenesis
VLDL 分泌受损、肝纤维化进展和逆转
- 批准号:
10396531 - 财政年份:2019
- 资助金额:
$ 35.57万 - 项目类别:
Bile acid metabolomics and metagenomics in short bowel syndrome
短肠综合征的胆汁酸代谢组学和宏基因组学
- 批准号:
9354486 - 财政年份:2016
- 资助金额:
$ 35.57万 - 项目类别:
Bile acid metabolomics and metagenomics in short bowel syndrome
短肠综合征的胆汁酸代谢组学和宏基因组学
- 批准号:
9248090 - 财政年份:2016
- 资助金额:
$ 35.57万 - 项目类别:
Molecul Biology of Intestinal Lipid Transport/Metabolism
肠道脂质运输/代谢的分子生物学
- 批准号:
6673433 - 财政年份:2003
- 资助金额:
$ 35.57万 - 项目类别:
相似国自然基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
- 批准号:31070748
- 批准年份:2010
- 资助金额:34.0 万元
- 项目类别:面上项目
相似海外基金
Optimal utility-based design of oncology clinical development programmes
基于效用的肿瘤学临床开发项目的优化设计
- 批准号:
2734768 - 财政年份:2026
- 资助金额:
$ 35.57万 - 项目类别:
Studentship
EAGER: Integrating Pathological Image and Biomedical Text Data for Clinical Outcome Prediction
EAGER:整合病理图像和生物医学文本数据进行临床结果预测
- 批准号:
2412195 - 财政年份:2024
- 资助金额:
$ 35.57万 - 项目类别:
Standard Grant
Exploring the Impact of Clinical Diagnosis on Health and Education Outcomes for Children Receiving Special Educational Needs support for Autism
探索临床诊断对接受自闭症特殊教育需求支持的儿童的健康和教育结果的影响
- 批准号:
ES/Z502431/1 - 财政年份:2024
- 资助金额:
$ 35.57万 - 项目类别:
Fellowship
Application of artificial intelligence to predict biologic systemic therapy clinical response, effectiveness and adverse events in psoriasis
应用人工智能预测生物系统治疗银屑病的临床反应、有效性和不良事件
- 批准号:
MR/Y009657/1 - 财政年份:2024
- 资助金额:
$ 35.57万 - 项目类别:
Fellowship
From lymphatics to evaluating resolution therapeutics in clinical trials
从淋巴管到评估临床试验中的解决疗法
- 批准号:
MR/Y013050/1 - 财政年份:2024
- 资助金额:
$ 35.57万 - 项目类别:
Fellowship
Strategy for improving clinical obesity therapeutics
改善临床肥胖治疗的策略
- 批准号:
MR/Y014707/1 - 财政年份:2024
- 资助金额:
$ 35.57万 - 项目类别:
Research Grant
VITAL: VIrtual Twins as tools for personalised clinicAL care
VITAL:虚拟双胞胎作为个性化临床护理的工具
- 批准号:
10106393 - 财政年份:2024
- 资助金额:
$ 35.57万 - 项目类别:
EU-Funded
Quantum-Enabled Brain Imaging: A Pathway to Clinical Utility
量子脑成像:临床应用的途径
- 批准号:
10107115 - 财政年份:2024
- 资助金额:
$ 35.57万 - 项目类别:
Small Business Research Initiative
Determining the clinical utility of BioEP: a multisite, prospective, study
确定 BioEP 的临床效用:一项多中心前瞻性研究
- 批准号:
10090508 - 财政年份:2024
- 资助金额:
$ 35.57万 - 项目类别:
Investment Accelerator
Presymptom: development of a novel machine-learning-derived diagnostic test to rule out infection to enable enhanced clinical care and better targeted anti-microbial use
症状前:开发一种新型的机器学习诊断测试来排除感染,从而加强临床护理和更有针对性的抗菌药物使用
- 批准号:
10089281 - 财政年份:2024
- 资助金额:
$ 35.57万 - 项目类别:
Investment Accelerator














{{item.name}}会员




